FIJYX Holdings Information

FIJYX is a mutual fund with a total of 98 individual holdings. The top holdings are AbbVie stock at 14.83%, Alnylam Pharmaceuticals at 5.52%, Gilead Sciences at 5.42%, Insmed at 3.51%, and Cogent Biosciences at 3.45%.

Total Holdings

Top 10 Percentage

48.77%

Asset Class

Equity

Fund Category

Health

Assets

1.90B

Forward PE Ratio

18.53

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	14.83%	1,335,480
2	ALNY	Alnylam Pharmaceuticals, Inc.	5.52%	339,486
3	GILD	Gilead Sciences, Inc.	5.42%	788,900
4	INSM	Insmed Incorporated	3.51%	489,600
5	COGT	Cogent Biosciences, Inc.	3.45%	1,834,818
6	DNTH	Dianthus Therapeutics, Inc.	3.37%	730,062
7	SYRE	Spyre Therapeutics, Inc.	3.33%	851,772
8	ASND	Ascendis Pharma A/S	3.24%	269,225
9	ARGX	argenx SE	3.17%	77,200
10	BIIB	Biogen Inc.	2.92%	294,100
11	ORKA	Oruka Therapeutics, Inc.	2.65%	737,386
12	AMGN	Amgen Inc.	2.46%	135,103
13	PCVX	Vaxcyte, Inc.	2.30%	763,629
14	RVMD	Revolution Medicines, Inc.	2.27%	299,500
15	NUVL	Nuvalent, Inc.	2.17%	412,264
16	AMLX	Amylyx Pharmaceuticals, Inc.	2.05%	2,433,200
17	APGE	Apogee Therapeutics, Inc.	1.97%	452,639
18	MRNA	Moderna, Inc.	1.55%	640,800
19	XENE	Xenon Pharmaceuticals Inc.	1.34%	456,458
20	VRDN	Viridian Therapeutics, Inc.	1.26%	1,782,464
21	KNSA	Kiniksa Pharmaceuticals International, plc	1.18%	417,600
22	ROIV	Roivant Sciences Ltd.	1.16%	776,700
23	JBIO	Jade Biosciences, Inc.	1.15%	894,343
24	PRAX	Praxis Precision Medicines, Inc.	1.14%	67,900
25	CRNX	Crinetics Pharmaceuticals, Inc.	1.11%	544,470

Showing 25 of 98 holdings

Subscribe to see the full list

Activate Now

As of Apr 30, 2026